Sort   by:  
 Page size 
TranscriptomicsToxicity and transcriptomic analysis in Hyalella azteca suggests increased exposure and susceptibility of epibenthic organisms to Zinc Oxide Nanoparticles
Abstract: Nanoparticles (NPs) are expected to make their way into the aquatic environment where sedimentation of particles will likely occur, putting benthic organisms at particular risk. Therefore, organisms such as Hyalella azteca, an epibenthic crustacean which forages at the sediment surface, ...
ORGANISM(S): Hyalella azteca 
2013-07-24 | E-GEOD-49136 | biostudies-arrayexpress
TranscriptomicsTranscription profiling of human post-mortem conjunctivae and corneal epithelia
Whole human conjunctivae and human corneas were obtained from the National Disease Research Interchange (NDRI, Philadelphia, PA) and processed between 48 - 72 hr of death. No donor details apart from age, sex and cause of death were released. Criteria for inclusion were donor ages between 25 - 65 ye...
ORGANISM(S): Homo sapiens 
2007-11-01 | E-GEOD-5543 | biostudies-arrayexpress
TranscriptomicsGene expression profile of the SV40-immortalized human corneal epithelial cells
Microarray was used to study global gene expression of a cell culture model based on SV40-immortalized human corneal epithelial (iHCE) cells. The gene expression profile of the cell line was compared to the normal human corneal epithelium. Affymetrix HG-U133A GeneChips® were used for microarray exp...
ORGANISM(S): Homo sapiens 
2010-07-29 | E-GEOD-22539 | biostudies-arrayexpress
TranscriptomicsDifferential Gene Expression in Daphnia magna Suggests Distinct Modes of Action and Bioavailability for ZnO nanoparticles and Zn ions
Zinc Oxide nanoparticles (ZnO NPs) are being rapidly developed for use in consumer products, wastewater treatment and chemotherapy providing several possible routes for ZnO NP exposure to humans and aquatic organisms. Recent studies have shown that ZnO NPs undergo rapid dissolution to Zn+2, but the...
ORGANISM(S): Daphnia magna 
2010-12-31 | E-GEOD-22051 | biostudies-arrayexpress
UnknownPalbociclib in Combination With Fulvestrant in Women With Hormone Receptor-Positive/HER2-Negative Advanced Metastatic Breast Cancer: Detailed Safety Analysis From a Multicenter, Randomized, Placebo-Controlled, Phase III Study (PALOMA-3).
Not available
S-EPMC5061543 | biostudies-literature
UnknownEffectiveness of Alpelisib + Fulvestrant Compared with Real-World Standard Treatment Among Patients with HR+, HER2-, PIK3CA-Mutated Breast Cancer.
Not available
S-EPMC8265362 | biostudies-literature
UnknownLong-term Pooled Safety Analysis of Palbociclib in Combination With Endocrine Therapy for HR+/HER2- Advanced Breast Cancer.
Not available
S-EPMC6449170 | biostudies-literature
UnknownPrognostic Factors for Overall Survival in Patients with Hormone Receptor-Positive Advanced Breast Cancer: Analyses From PALOMA-3.
Not available
S-EPMC8342589 | biostudies-literature
UnknownSharing brain mapping statistical results with the neuroimaging data model.
Not available
S-EPMC5139675 | biostudies-literature
UnknownAmyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI.
Not available
S-EPMC4831042 | biostudies-literature
Sort   by:  
 Page size